4 recruiting, 1 not yet recruiting. 5 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 4, Not yet recruiting 1 |
| Phase 3 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow baotai Liang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study homoharringtonine, Radical prostatectomy - Prostate Cancer | Phase 2 | Recruiting | baotai Liang | 93 | 2025-04-20 | 2025-11-18 |
| Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer Homoharringtonine combined with androgen deprivation therapy, Placebo combined with androgen deprivation treatment group, radical prostatectomy - Prostate CA | Phase 2 | Recruiting | baotai Liang | 96 | 2025-03-19 | 2025-09-08 |
| Clinical Study of Geranium Wilfordii Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer Geranium wilfordii combined with androgen deprivation treatment, Androgen deprivation treatment, radical prostatectomy - Prostate CA | Phase 2 / Phase 3 | Not yet recruiting | baotai Liang | 95 | 2025-03-10 | 2025-03-06 |
| Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer Fasudil hydrochloride and PD1 inhibitor combined with androgen deprivation therapy, Placebo combined with androgen deprivation therapy, radical prostatectomy - Prostate CA | Phase 2 / Phase 3 | Recruiting | baotai Liang | 83 | 2025-02-16 | 2025-11-18 |
| A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer Fasudil hydrochloride combined with immunotherapy - Prostate Cancer | Phase 2 | Recruiting | baotai Liang | 30 | 2024-07-05 | 2025-11-26 |
Androgen Antagonists (2) · Drug Therapy (1) · Homoharringtonine (1) · Immunotherapy (1) · Surgical Procedures, Operative (1) · fasudil (1)
China (4)